The effect of simvastatin co-medication on warfarin anticoagulation response and dose requirements

被引：32
作者：
Hickmott, H [1 ]
Wynne, H [1 ]
Kamali, F [1 ]
机构：
[1] Univ Newcastle Upon Tyne, Wolfson Unit Clin Pharmacol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
来源：
THROMBOSIS AND HAEMOSTASIS | 2003年 / 89卷 / 05期
关键词：
D O I：
10.1055/s-0037-1613486
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：949 / 950
页数：2
相关论文
共 7 条
  • [1] Collins R, 2002, INT J CLIN PRACT, V56, P53
  • [2] FEELY J, 1991, DRUG INVEST, V5, P315
  • [3] 3-YEAR FOLLOW-UP OF THE OXFORD-CHOLESTEROL-STUDY - ASSESSMENT OF THE EFFICACY AND SAFETY OF SIMVASTATIN IN PREPARATION FOR A LARGE MORTALITY STUDY
    KEECH, A
    COLLINS, R
    MACMAHON, S
    ARMITAGE, J
    LAWSON, A
    WALLENDSZUS, K
    FATEMIAN, M
    KEARNEY, E
    LYON, V
    MINDELL, J
    MOUNT, J
    PAINTER, R
    PARISH, S
    SLAVIN, B
    SLEIGHT, P
    YOUNGMAN, L
    PETO, R
    [J]. EUROPEAN HEART JOURNAL, 1994, 15 (02) : 255 - 269
  • [4] LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449
  • [5] Effects of drugs on postprandial lipoprotein metabolism
    Packard, CJ
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 1997, 56 (02) : 745 - 751
  • [6] In vitro comparative inhibition profiles of major human drug metabolising cytochrome p450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors
    Transon, C
    Leemann, T
    Dayer, P
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 50 (03) : 209 - 215
  • [7] WALKER JF, 1987, AM J MED, V87, P445
1